Publications by authors named "Brandon Sheffield"

Claim this Profile
N
Novel Approach to Proficiency Testing Reveals Significant Variations in Biomarker Practice Leading to Critical Differences in Lung Cancer Management.
Kassandra R Bisson, Andrea Beharry, Normand Blais, Michael D Carter, Parneet K Cheema, Brandon S Sheffield

JTO Clin Res Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemigatinib in the Real-World Management of Cholangiocarcinoma Through a Canadian Patient Support Program.
Philip Q Ding, Vincent C Tam, Ravi Ramjeesingh, Jamil Asselah, Brandon S Sheffield

Curr Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian consensus for the assessment and testing of Lynch syndrome.
Melyssa Aronson, Laura Palma, Kara Semotiuk, Jennifer Nuk, Aaron Pollett, Brandon S Sheffield

J Med Genet· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in Canada.
Brandon S Sheffield, Shantanu Banerji, Allen Chankowsky, Shaan Dudani, Sharlene Gill

Curr Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction Adenocarcinoma.
Christine Brezden-Masley, Pierre O Fiset, Carol C Cheung, Thomas Arnason, Justin Bateman, Brandon S Sheffield

Curr Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario Forum.
Parneet K Cheema, Paul F Wheatley-Price, Matthew J Cecchini, Peter M Ellis, Alexander V Louie, Brandon S Sheffield

Curr Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Liquid Biopsy in Non-Small-Cell Lung Cancer: An Ontario Perspective.
Daniel Breadner, David M Hwang, Don Husereau, Parneet Cheema, Sarah Doucette, Brandon S Sheffield

Curr Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study.
Parneet K Cheema, Iqra Syed, Femida Gwadry-Sridhar, Muhammad Rakibuz-Zaman, Robin Sachdeva, Brandon S Sheffield

Curr Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
Umberto Malapelle, Natasha Leighl, Alfredo Addeo, Dov Hershkovitz, Maximilian J Hochmair, Brandon S Sheffield

Br J Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point of Care Liquid Biopsy for Cancer Treatment-Early Experience from a Community Center.
Champica Nicholas, Andrea Beharry, Anna M Bendzsak, Kassandra R Bisson, Keith Dadson, Brandon S Sheffield

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization Study.
Martin D Hyrcza, Sebastiao N Martins-Filho, Alan Spatz, Han-Jun Wang, Bibianna M Purgina, Brandon S Sheffield

Mod Pathol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1.
Mónica Fumero-Velázquez, Michael Hagstrom, Soneet Dhillon, Tara Geraminejad, Shantel Olivares, Brandon S Sheffield

Am J Surg Pathol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies.
Sally C M Lau, Kirstin Perdrizet, Andrea S Fung, Danilo Giffoni M M Mata, Jessica Weiss, Brandon Sheffield

JTO Clin Res Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.
Parneet K Cheema, Shantanu O Banerji, Normand Blais, Quincy S-C Chu, Rosalyn A Juergens, Brandon S Sheffield

Curr Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Point-of-Care Genomic Profiling in the Diagnosis and Treatment of Cancer of Unknown Primary.
Xin Wang, Andrea Beharry, Brandon S Sheffield, Parneet K Cheema

Oncologist· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress toward Health System Readiness for Genome-Based Testing in Canada.
Don Husereau, Eva Villalba, Vivek Muthu, Michael Mengel, Craig Ivany, Brandon Sheffield

Curr Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CANTRK: A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next-Generation RNA Sequencing.
Tracy L Stockley, Bryan Lo, Adrian Box, Andrea Gomez Corredor, John DeCoteau, Brandon S Sheffield

J Mol Diagn· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus Recommendations to Optimize the Detection and Reporting of Gene Fusions by RNA-Based Next-Generation Sequencing.
Tracy L Stockley, Bryan Lo, Adrian Box, Andrea Gomez Corredor, John DeCoteau, Brandon S Sheffield

Curr Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices.
Brandon S Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts

Curr Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada.
M Sara Kuruvilla, Geoffrey Liu, Iqra Syed, Femida Gwadry-Sridhar, Brandon S Sheffield

Lung Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective and Efficient Delivery of Genome-Based Testing-What Conditions Are Necessary for Health System Readiness?
Don Husereau, Lotte Steuten, Vivek Muthu, David M Thomas, Daryl S Spinner, Brandon Sheffield

Healthcare (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the delivery of genetic and advanced diagnostic testing in the province of Ontario: challenges and implications for laboratory technology assessment and management in decentralized healthcare systems.
Don Husereau, Terrence Sullivan, Harriet E Feilotter, Marcio M Gomes, Rosalyn Juergens, Brandon S Sheffield

J Med Econ· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Biomarker Testing for Metastatic Colorectal Cancer: a Canadian Consensus Practice Guideline.
Irene S Yu, Francine Aubin, Rachel Goodwin, Jonathan M Loree, Cheryl Mather, Brandon S Sheffield

Ther Adv Med Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021.
Eliya Farah, Maria El Bizri, Radmila Day, Lavina Matai, Fred Horne, Brandon S Sheffield

Curr Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care.
Brandon S Sheffield, Andrea Beharry, Joanne Diep, Kirstin Perdrizet, Marco A J Iafolla

Curr Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis